Swedish Pharmaceuticals & Biotech Potentially Undervalued Companies

AddLife

Market Cap: SEK 19.2b

Provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries.

Camurus

Market Cap: SEK 32.2b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

Alvotech

Market Cap: SEK 1.1b

Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.

Cantargia

Market Cap: SEK 508.7m

A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.

AstraZeneca

Market Cap: SEK 214.0b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

BICO Group

Market Cap: SEK 1.2b

Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.

Swedish Orphan Biovitrum

Market Cap: SEK 153.6b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

Saniona

Market Cap: SEK 1.8b

A clinical-stage biopharmaceutical company, focuses on discovering, developing, and delivering innovative treatments for neurological and psychiatric disorders in Ireland, the United States, Germany, Denmark, and the United Kingdom.

Sprint Bioscience

Market Cap: SEK 345.0m

A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.

Double Bond Pharmaceutical International

Market Cap: SEK 12.9m

A pharmaceutical company, engages in the development and commercialization of approaches for the treatment of oncological and infectious diseases.

Bonesupport Holding

Market Cap: SEK 15.1b

An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.

Vitrolife

Market Cap: SEK 13.2b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

ODI Pharma

Market Cap: SEK 51.0m

A pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe.

Subgen AI

Market Cap: SEK 90.6m

Develops artificial intelligence-based models and applications to control data for government and businesses.

Guard Therapeutics International

Market Cap: SEK 26.4m

A clinical-stage biotechnology company, identifies and develops medicines to treat kidney diseases in Sweden.

Chosa Oncology

Market Cap: SEK 34.4m

Develops oncology drugs cisplatin for the treatment of cancer.

Inhalation Sciences Sweden

Market Cap: SEK 65.8m

Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research.

AcouSort

Market Cap: SEK 92.9m

A technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets.

Xbrane Biopharma

Market Cap: SEK 212.2m

A biotechnology company, engages in the development, manufacture, and sale of biosimilars.

Devyser Diagnostics

Market Cap: SEK 1.5b

Provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.

Genovis AB (publ.)

Market Cap: SEK 1.3b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

Magle Chemoswed Holding

Market Cap: SEK 62.0m

Engages in research and development of pharmaceutical and medical device products in Sweden.

BioGaia

Market Cap: SEK 12.4b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

BioInvent International

Market Cap: SEK 1.9b

A clinical-stage company, discovers and develops immuno-modulatory antibodies for cancer therapy in Sweden, Europe, the United States, and internationally.

Biovica International

Market Cap: SEK 105.4m

A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the European Union, United States of America, and internationally.

IRLAB Therapeutics

Market Cap: SEK 105.3m

IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson’s disease and other central nervous system (CNS) disorders in the United States.

Oncopeptides

Market Cap: SEK 677.9m

A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.

ExpreS2ion Biotech Holding

Market Cap: SEK 5.7m

A biotechnology company, develops vaccines and biologics products to address critical unmet medical needs in the Nordics and internationally.

MedCap

Market Cap: SEK 7.6b

A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout.